Rutherford Diagnostics

Rutherford Diagnostics aspires to be at the forefront of revolutionising healthcare by becoming a leader in the prediction, prevention and earliest possible detection of disease, as well as being equipped to conduct the most complex of diagnostic tests across a wide range of conditions using the latest technologies. The company’s goal is to reduce waiting times for diagnostic tests from weeks to days and develop real partnerships with private healthcare and NHS organisations to help achieve this.At the heart of Rutherford Diagnostics will be genomics, the recording of whole genome sequence data which will be used to predict disease, susceptibility, and treatment and drug response. The core technologies Rutherford Diagnostics will provide include Spectral CT, digital PET-CT, 3T MRI, ultrasound, endoscopy, and a commercial genomics laboratory.